Clinical Trial Update: Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating the effects of GLP-1 receptor agonists on weight and metabolic indicators in obese patients is reported as ongoing or sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Obesity | Phase 3 | Status: UNKNOWN